AbbVie Valuation

AbbVie Inc -- USA Stock  

USD 118.60  0.69  0.59%

AbbVie Inc shows prevailing Real Value of $98.58574999999999 per share. The current price of the firm is $118.6. At this time the firm appears to be over valued. Macroaxis approximates value of AbbVie Inc from analyzing the firm fundamentals such as Profit Margin of 18.82% and Return On Equity of 93.77% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.

Valuation Drivers Correlation

Selected AbbVie Inc Valuation Data Over Time

Net Income Per Employee    Enterprise Value    Market Capitalization    
 Time Horizon     30 Days    Login   to change
AbbVie Inc is number one stock in price to sales category among related companies. It is rated third in price to earning category among related companies reporting about  5.36  of Price to Earning per Price to Sales.
Over Valued
February 22, 2018
118.60
Market Value
Downside upside
98.59
Real Value
Target Price Odds
 Above  Below  
130.46
Upside
Upside upside
AbbVie is not too volatile asset. Calculation of real value of AbbVie Inc is based on 1 month time horizon. Increasing AbbVie Inc time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Recommendations

AbbVie Analyst Recommendations
Target PriceAdvice# of Analysts
74.42Hold12Odds
AbbVie Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
AbbVie Analyst Advice  

Tax Efficiency

AbbVie Inc Tax Efficiency History

Tax Efficiency

Market Capitalization

AbbVie Market Capitalization Analysis
AbbVie Inc is number one stock in market capitalization category among related companies. Market capitalization of Pharmaceuticals And Biosciences industry is presently estimated at about 394.5 Billion. AbbVie totals roughly 189.34 Billion in market capitalization claiming about 48% of equities listed under Pharmaceuticals And Biosciences industry.
Capitalization  Workforce  Revenue  Total debt  Valuation

Revenue

AbbVie Inc Revenue
Based on latest financial disclosure AbbVie Inc reported 28.22 B of revenue. This is 334.16% higher than that of the Healthcare sector, and significantly higher than that of Pharmaceuticals And Biosciences industry, The Revenue for all stocks is 186.6% lower than the firm.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.